TrialScientific reports2026
Population pharmacokinetics and target attainment of pretomanid in rifampicin-resistant tuberculosis patients.
Bern-Thomas Nyang'wa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papertrialcites it